Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:98 (8 July), doi:10.1136/bmj.333.7558.98-a
| The first 150 words of the full text of this article appear below. |
EDITORDeeks singled out drug availability and limited resources in terms of equipment as some of the constraints facing Africa with regard to antiretroviral treatment.1 Globally, financial resources are not regarded as the main immediate constraint anymore, the lack of human resources for health being regarded as the single most serious obstacle to the roll out of antiretroviral treatment.2-5
Not only is the number of health professionals for national health systems in general insufficient but there is even a greater shortage of staff involved in antiretroviral treatment. The few human resources available are maldistributed, most staff residing in urban areas. When this is coupled with unsatisfactory working conditions characterised by overwork, lack of support, burnout, and lack of equipment, people are simply overwhelmed. The production of health professionals by institutions of higher learning is not on the increase as might be expected, and the capping of the number of
Ntambwe Malangu, senior lecturer
University of Limpopo, South Africa gustavmalangu@gmail.com